Literature DB >> 29861660

Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia.

Sherif M Badawy1, Kerry Morrone2, Alexis Thompson1, Tonya M Palermo3.   

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To identify and assess the effects of computer and mobile technology interventions designed to facilitate medication adherence and disease management in individuals with thalassemia, including: evaluating the effects of using computer and mobile technology interventions for medication adherence and disease management on health and behavioural outcomes;identifying and assessing the effects of computer and mobile technology interventions specific to different age groups (children, adolescents and adults) and type of modality (e.g. cell phone, the Internet).

Entities:  

Year:  2017        PMID: 29861660      PMCID: PMC5978731     

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  48 in total

1.  Social networks and collateral health effects.

Authors:  Nicholas A Christakis
Journal:  BMJ       Date:  2004-07-24

Review 2.  The molecular basis of α-thalassemia: a model for understanding human molecular genetics.

Authors:  Douglas R Higgs; Richard J Gibbons
Journal:  Hematol Oncol Clin North Am       Date:  2010-09-29       Impact factor: 3.722

3.  Relationship among chelator adherence, change in chelators, and quality of life in thalassemia.

Authors:  Felicia L Trachtenberg; Eric Gerstenberger; Yan Xu; Lauren Mednick; Amy Sobota; Hannah Ware; Alexis A Thompson; Ellis J Neufeld; Robert Yamashita
Journal:  Qual Life Res       Date:  2014-03-30       Impact factor: 4.147

Review 4.  Stress, social support, and the buffering hypothesis.

Authors:  S Cohen; T A Wills
Journal:  Psychol Bull       Date:  1985-09       Impact factor: 17.737

5.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

6.  Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-Thalassemia: Results from the ESCALATOR Trial.

Authors:  Ali Taher; Abdullah Al Jefri; Mohsen Saleh Elalfy; Kusai Al Zir; Shahina Daar; Diana Rofail; Jean François Baladi; Dany Habr; Ulrike Kriemler-Krahn; Amal El-Beshlawy
Journal:  Acta Haematol       Date:  2010-04-27       Impact factor: 2.195

Review 7.  Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.

Authors:  Kristin Loiselle; Jennifer L Lee; Lauren Szulczewski; Sarah Drake; Lori E Crosby; Ahna L H Pai
Journal:  J Pediatr Psychol       Date:  2015-09-18

8.  Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease.

Authors:  Sherif M Badawy; Alexis A Thompson; Robert I Liem
Journal:  Pediatr Blood Cancer       Date:  2016-02-04       Impact factor: 3.167

9.  Usability and Feasibility of an mHealth Intervention for Monitoring and Managing Pain Symptoms in Sickle Cell Disease: The Sickle Cell Disease Mobile Application to Record Symptoms via Technology (SMART).

Authors:  Charles R Jonassaint; Nirmish Shah; Jude Jonassaint; Laura De Castro
Journal:  Hemoglobin       Date:  2015-04-01       Impact factor: 0.849

10.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.